Status:
NOT_YET_RECRUITING
Cannabis Association With Sleep Study
Lead Sponsor:
Oregon Health and Science University
Conditions:
Sleep
Eligibility:
All Genders
21-29 years
Phase:
NA
Brief Summary
The purpose of this study is to learn more about cannabis use, sleep, and stress, and whether there is any relationship between the three.
Detailed Description
After passing a physical assessment and psychological screen, 60 participants will be enrolled. Ahead of the 21-day protocol participants will report to our laboratory sleep facilities and will be set...
Eligibility Criteria
Inclusion
- fluent in English
- 5\<BMI\<40 kg/m2
- no shift work in the last 12 months
- no travel across time zones in the last 2 months.
Exclusion
- Chronic disease-Medical history/prior diagnosis of the following:
- cardiometabolic disease (e.g., myocardial infarction, angina, diabetes)
- essential hypertension
- hepatic impairment
- severe obstructive sleep apnea
- restless legs syndrome
- parasomnia
- neurological disease (e.g., early onset dementia)
- unstable psychiatric disorders (e.g., bipolar disorder, schizophrenia, major depression with suicidality).
- Drug/Alcohol use criteria:
- Illicit drugs apart from cannabis or related products are prohibitive.
- Volunteers may consume caffeine, however, \>3 cups of coffee (or otherwise equivalent of \>300mg/day) is prohibitive.
- Participants who consume \>14 alcoholic drinks/week and/or have a diagnosis (or history) of alcohol use disorder will be excluded (a toxicological urine screen will be conducted to verify reported non-use during the initial screening and on the day of admission to the in-laboratory portion of the study).
- Use of prescription or over-the-counter medications or supplements that affect sleep are also exclusionary.
- Contraceptives are required for women and will continue to be taken throughout the experiment.
- Prior Shift Work:
- Volunteers must have no history of working irregular day and night hours, regular night work, or rotating shift work for the 3 months prior to the study.
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2032
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06982950
Start Date
July 1 2025
End Date
June 30 2032
Last Update
May 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.